Amara Okafor
Amara Okafor reads hormone, skin, and metabolic crossover studies. She tracks endpoints like barrier function, pigmentation, hormone levels, and body weight over time. Her writing separates short term findings from longer follow up data. She uses careful phrasing around mixed results and does not assign meaning beyond the measured outcome. Her posts often pair a hormone study with a skin or metabolic study when the underlying pathway overlaps.
Posts
Studies4 min read
Microneedling with GHK-Cu works in models but human trials lag
Two 2026 reviews find microneedling helps GHK-Cu cross the skin barrier in lab and pig-skin models, yet the human evidence remains small and mixed.
Studies3 min read
Low kisspeptin-10 predicted early pregnancy loss in a study
Three new studies measured kisspeptin-10 as a blood marker instead of testing it as a treatment. Lower levels in early pregnancy were linked to a higher chance of pregnancy loss, while higher levels appeared in women with unexplained infertility and PCOS.
Studies5 min read
Testosterone and GH with hMG raised pregnancy rates in low responders
Three new studies looked at hMG from different angles. One clinic review found that adding testosterone gel and growth hormone to hMG raised pregnancy rates in younger women with low ovarian reserve.
Studies5 min read
Kisspeptin-10 kept LH up for 12 days in healthy men
Three new studies show what Kisspeptin-10 can and cannot sustain: daily 8-hour infusions kept luteinizing hormone elevated for 12 days in healthy men, while mouse and rat work adds new metabolic and developmental findings.
Studies5 min read
GHK-Cu skin effects depend on formulation and copper form
New GHK-Cu reviews agree on anti-inflammatory and skin matrix protection in lab models. Human trial evidence remains small and varies with the copper form and delivery system tested.